Clinical Trial Details
— Status: Completed
Administrative data
| NCT number |
NCT02161341 |
| Other study ID # |
R1146/48/2014 |
| Secondary ID |
2014/520/A |
| Status |
Completed |
| Phase |
|
| First received |
|
| Last updated |
|
| Start date |
June 2014 |
| Est. completion date |
October 2018 |
Study information
| Verified date |
October 2018 |
| Source |
Singapore National Eye Centre |
| Contact |
n/a |
| Is FDA regulated |
No |
| Health authority |
|
| Study type |
Observational
|
Clinical Trial Summary
The ocular surface is the first line of defence of the eye, it is therefore where external
threats are sensed, and potential insults neutralised. Over the course of evolution, various
microbes, especially bacteriae, have come to colonise the ocular surface as commensals. The
commensals have a role to maintain the homeostasis of the ocular surface. 1 The innate
immunity of the ocular surface is very active, and consists of active mechanisms to suppress
inflammation 2. For example, there exist macrophages, dendritic cells, suppressor cells,
regulatory cells, B cells, IgA, lysozyme, anti-microbial peptides and barriers against
external agents. The normal commensals of the ocular surface maintain a basal level of
activation of innate defence by stimulating the pattern recognition receptors on ocular
surface epithelial cells. This normal composition of microbes is important since inflammation
and infection will result if there is introduction of a pathogenic strain that overcomes the
flora, or if a dominant strain secretes excessively immunogenic products, such as the
exotoxin A of Staphylococcus which triggers marginal keratitis, a form of type IV
hypersensitivity. The flora load of microbiome could also influence tear function as a higher
flora load was found to be associated with increased mucin degradation 3 and reduced globet
cell densitiy 4. Previous studies [I'm not sure which studies these are] at SERI/SNEC also
point to the importance of microbes. For example, in dry eye patients, there is increased
lysophospholipids in the tear, and this may contribute to inflammatory mediators such as
arachidonic acid and other metabolites. The lysophospholipids are formed by phospholipase A2
reactions, and the latter may be microbial in origin. Since dry eye is a known inflammatory
disease of the ocular surface, this is one way that microbes can contribute to the pathology.
Description:
The ocular surface is the first line of defense of the eye, it is therefore where external
threats are sensed, and potential insults neutralised. Over the course of evolution, various
microbes, especially bacteriae, have come to colonise the ocular surface as commensals. The
commensals have a role to maintain the homeostasis of the ocular surface. 1 The innate
immunity of the ocular surface is very active, and consists of active mechanisms to suppress
inflammation 2. For example, there exist macrophages, dendritic cells, suppressor cells,
regulatory cells, B cells, IgA, lysozyme, anti-microbial peptides and barriers against
external agents. The normal commensals of the ocular surface maintain a basal level of
activation of innate defence by stimulating the pattern recognition receptors on ocular
surface epithelial cells. This normal composition of microbes is important since inflammation
and infection will result if there is introduction of a pathogenic strain that overcomes the
flora, or if a dominant strain secretes excessively immunogenic products, such as the
exotoxin A of Staphylococcus which triggers marginal keratitis, a form of type IV
hypersensitivity. The flora load of microbiome could also influence tear function as a higher
flora load was found to be associated with increased mucin degradation 3 and reduced globet
cell densitiy 4. Previous studies [I'm not sure which studies these are] at SERI/SNEC also
point to the importance of microbes. For example, in dry eye patients, there is increased
lysophospholipids in the tear, and this may contribute to inflammatory mediators such as
arachidonic acid and other metabolites. The lysophospholipids are formed by phospholipase A2
reactions, and the latter may be microbial in origin. Since dry eye is a known inflammatory
disease of the ocular surface, this is one way that microbes can contribute to the pathology.
The microbiome is the sum total of the microbe found in a body location. In the eye the
microbiome can be investigated non-invasively because of the accessible location of the
ocular surface. Despite the importance of the ocular surface microbiome, understanding of
this topic is very superficial and largely based on culture methods5-10. This can be
misleading because some of the microbes are not so amenable to routine cell cultures and
their presence may be undetected or their representation under-estimated 11. Recently
developed metagenomics sequencing, compared to cultures, are advantageous to get an un-biased
view of microbiome11.
Three prior studies have evaluated the microbiome profiles of the ocular surface with
metagenomics sequencing of 16s rRNA 4, 12 13. Differences in microbiome were observed between
subjects with dry eyes or blepharitis, and healthy subjects. Moreover, a much greater
diversity of ocular flora was discovered compared to results based on bacterial culture.
The school of chemical and environmental life science at Nanyang Technological University has
evaluated the microbiomes using such techniques. The basis of this is that prokaryotic
organisms have unique DNA signatures which can typically characterise the species of origin,
and the relative prevalence of the organisms of different species can be deduced from the
relative abundance of the different DNA detected. The global human microbiome project seeks
to understand the microbiome in different parts of the human body. This is best understood in
the intestine, but publications on the ocular surface have yet to emerge.
Recently our collaborators have been found that 3 bacteria dominated the ocular surface of
the eye. These are Klebsiella pneumoniae, Pseudoalteromonas agarivorans and Lactobacillus
rhamnosus. This dominance of 3 types of bacteria was unexpected, since the dominant view of
ocular surface commensals is that coagulase negative Staphylococcus dominates, followed by
Staphylococcus aureus and Streptococcus, with less gram negative bacteria, and some
Propionibacter spp 11. Among the 3 species, Klebsiella pneumonia is a known gram negative
pathogen that can cause infectious keratitis, and in some cases endophthalmitis. The roles of
Pseudoalteromonas and Lactobacillus are entirely unknown. The former is a non-pathogenic free
living gram negative bacteria known to be present in marine settings. Surprisingly the high
levels of the 3 predominant bacteria are relatively constant among the 3 human participants,
suggesting a certain amount of uniformity in the colonisation of the ocular surface by major
bacteria microbes in non-diseased individuals.
The ocular surface microbiome can be studied by sterile swapping of the inferior fornix of
the conjunctiva followed by homogenisation and extraction of DNA. The presence of bacteria
DNA does not inform on the function of the microbes, since even dead and non-proliferating
organisms have remnant DNA. The technique of collecting samples can also yield RNA, and from
reverse transcription PCR, it is possible to determine the presence of specific microbial
transcripts that are found in the ocular surface. Furthermore, our collaborators from Nanyang
Polytechnic have pioneered MALDI TOF mass spectrometry techniques that allow the
characterisation of bacterial proteomes, based on identification of unique bacterial peptide
sequences. Together, these techniques of bacteria transcript and protein investigations
permit evaluation of the gene expression and to some extent, functional status of the
bacteria discovered. This would be extremely important in the case of microbes that have not
been previously discovered on the ocular surface.
Apart from the obvious academic and scientific advance, this project also has medical
implications and potential new Intellectual property for commercial applications. First,
understanding of the microbiome is the first step to treat certain types of diseases such as
marginal keratitis and unusual infectious keratitis. It suggests how the immune system can be
manipulated for treatment. Secondly, prevention of diseases and inflammation may be achieved
by probiotic administration of living microbes to colonise the ocular surface. Third, the
study may lead to new techniques and assays that identify microbes and their components which
can be developed into clinical diagnostic assays.
We have some industry collaborators who are interested to partner us to develop some of these
ideas.
1. OBJECTIVES
We aim to conduct an exploratory study to:
1. Determine the composition of the bacterial microbiome of the human ocular surface in
normal volunteers and dry eye patients
2. Determine the bacterial gene expression (bacterial transcripts) found in the human
ocular surface.
3. Characterise any feature of the microbiome that may be linked to clinical
characteristics such as age, status of tearfilm, Meibomian gland dysfunction, exposure
to environmental stimulation such as smoking, etc.
2. EXPECTED RIKS AND BENEFITS Expected risks No potential problems are expected for this
study. However, there will be some slight discomfort during the collection of microbiome from
the lower conjunctival fornix. Non-preservative tetracaine will be given to the patient to
minimise any discomfort. There will also be some slight discomfort during the Schimers I
test.
Potential benefits With greater understanding of the presence of various microbiome in the
ocular surface, we can gain further insight into the complex process taking place.
3. STUDY POPULATION 3.1. List the number and nature of subjects to be enrolled. 90 subjects
will be recruited from SNEC dry eye clinic and general clinic serviced by the Principal
Investigator. 45 subjects without dry eye symptoms will be recruited as normal controls and
45 subjects with symptomatic dry eye will be recruited as dry eye subjects.
3.2. Criteria for Recruitment and Recruitment Process
1. To recruit normal controls- All the 8 questions on dry eye symptoms must be clear of dry
eye symptoms during the pre-screening stage. (Appendix 1) Questionnaire modified after
Schein et al.,1997. To recruit dry eye subjects- At least one out of the 8 questions on
dry eye symptoms must be ≥ grade 3
2. Subjects meet all the inclusion criteria listed below.
3. Clear of exclusion criteria. Permission would be sought from the attending doctors
before subjects are being recruited. Eligible subjects will be counselled on the study
by study coordinator. If the subject is interested, the study coordinator will then
accompany the subject to SERI level 5 for the relevant assessments. Informed written
consent will be obtained from all participants.
3.3. Inclusion Criteria
Subject must meet all of the inclusion criteria to participate in this study.
1. Subjects must be 21 years or older
2. Willing to perform all the eye examinations in this study
3.4. Exclusion Criteria
All subjects meeting any of the exclusion criteria at baseline will be excluded from
participation.
1. Known history of thyroid disorders (diagnosed by physician).
2. Known history of Sjogren syndrome or rheumatoid arthritis (diagnosed by physician).
3. No ocular surgery within the last 3 months and LASIK within 1 year.
4. Ocular surface diseases such as pterygium, or obvious lid/orbital disease with
lagophthalmos.
5. Any other specified reason as determined by clinical investigator.
4. STUDY DESIGN AND PROCEDURES/METHODOLOGY
Study design:
Observational -Cross sectional study
No. of visits:
There will only be 1 visit in this study.
Duration of Study:
1 year
Procedures:
Collection of Medical history and Dry Eye Questionnaire There will be some questionnaire
which consists of medical history and a standard set of dry eye questionnaires which
identifies factors such as contact lens use, smoking, occupation and etc.
Non-Invasive Tear Break-Up Time (OCULUS K5M) Non-Invasive Tear Break-Up Time is measured
non-invasively and fully automatically using OCULUS K5M. The new infrared illumination is not
visible to the human eye. This prevents glare during the examination. Patient will sit
comfortably in front of the instrument and blink freely while fixing on a target directly
ahead. Once the participant is ready, they will be instructed to blink twice and refrain from
blinking. Keratograph 5M is fully automated and it will capture any break or distortion in
the image and the time of the break will be noted. Three readings will be taken for each eye
to get the average value.
Conjunctiva redness (OCULUS K5M) Conjunctiva redness will be assessed using OCULUS K5M.
Patient will sit comfortably in front of the instrument while fixing on a target directly
ahead. Imaged will be captured and an overview display of conjunctiva redness will be
evaluated by "JENVIS Grading Scale". JENVIS scale range from 0 to 4.
Redness value Definition 0 No findings, eg. Babies or infants
1. Single injections, standard value for adults
2. Mild diffuse injections
3. Severe local injections
4. Severe diffuse injections
Collection of microbiome Two specimens of microbiome will be collected from both eyes. First:
a drop of non-preserved tetracaine will be instilled into the conjunctival fornix. After the
stinging sensation has resolved, a sterile cotton swap will be used to collect the microbes
from the lower conjunctival fornix using a gentle rolling action (up to 8 strokes). The
procedure is then repeated for the opposite eye.
These swaps will then be soaked in DNA/RNA Shield (Zymo) reagent and immediately homogenised
for 1 minute, stop at 30 seconds, and keep on ice for 1 minute, and homogenized for another
30 seconds. Homogenised samples will be stored at 4°C. This ensures an optimal and sufficient
DNA/RNA yield for our purpose. Subsequent nucleic acid extraction, PCR, sequencing, and
bioinformatics procedures will be performed by our collaborators.
Storage: intended to be analysed within a year, not more than 5 years.
Corneal fluorescein staining (OCULUS K5M) A drop of normal saline will be instilled on the
fluorescein strip (Fluorets) then shaken off so that no visible drop remains. The subject is
asked to look up before the introduction of the fluoret to the inferior conjunctival fornix
on the right then left eye. Corneal fluorescein staining will be imaged by Keratograph 5M.
Scoring system will be based on CCLRU. Briefly, there will be 5 corneal zones. The staining
scale is 0-4, with 0.5 unit steps in each of the zones. Lastly, a picture of the fluorescein
stained cornea will be taken.
Schirmers I test This will be done with the standard strips currently used at SERI (5 mm wide
with a notch for folding) (Schirmer Tear Test Strips, Clement Clarke International, UK). No
prior anesthetic will be used. The strips will be positioned over the inferior temporal half
of the lower lid margin in both eyes at the same time. The study participant will be asked to
close their eyes. Any excessive irritation signs will be noted. The extent of the wetting in
each strip will be recorded after 5 minutes of testing. The strip will be collected and
stored in 1.5ml eppendorf tubes at -80˚C until further analysis.
